Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Published:2016-06 Issue:10036 Volume:387 Page:2402-2411
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ribrag Vincent,Koscielny Serge,Bosq Jacques,Leguay Thibaut,Casasnovas Olivier,Fornecker Luc-Mathieu,Recher Christian,Ghesquieres Hervé,Morschhauser Franck,Girault Stéphane,Gouill Steven Le,Ojeda-Uribe Mario,Mariette Clara,Cornillon Jerome,Cartron Guillaume,Verge Veronique,Chassagne-Clément Catherine,Dombret Hervé,Coiffier Bertrand,Lamy Thierry,Tilly Hervé,Salles Gilles

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Burkitt's lymphoma: molecular pathogenesis and treatment;Bishop;Cancer Invest,2000

2. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis;Diviné;J Clin Oncol,1996

3. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to proMACE-based combination chemotherapy;Longo;J Clin Oncol,1994

4. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients;Jost;Ann Oncol,1995

5. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society;Patte;J Clin Oncol,1986

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell non-Hodgkin lymphomas;The Lancet;2024-05

2. Long-Term Survival Rates and Treatment Trends of Burkitt Lymphoma in Patients with HIV—A National Cancer Database (NCDB) Study;Cancers;2024-04-02

3. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies;Blood and Lymphatic Cancer: Targets and Therapy;2024-03

4. Effect of rituximab on immune status in children with aggressive mature B-cell lymphoma/leukemia–a prospective study from CCCG-BNHL-2015;Heliyon;2024-03

5. Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study;Technology in Cancer Research & Treatment;2024-01